Nanoparticles treat muscular dystrophy in mice

Researchers at the School of Medicine have demonstrated a new approach to treating muscular dystrophy. Mice with a form of the disease showed improved strength and heart function when treated with nanoparticles loaded with rapamycin, an immunosuppressive drug recently found to improve recycling of cellular waste.

Washington People: Karen Seibert

Karen Seibert, PhD, research professor of pathology and immunology and of genetics, helps scientists connect and collaborate. Seibert, who does so with a mixture of warmth, optimism, enthusiasm and humor, is the director of Genomic Pathology Services at Washington University, a groundbreaking service that simultaneously analyzes many different genes to help patients and their doctors identify the best treatment options.
Older Stories